RayzeBio Revenue and Competitors
Estimated Revenue & Valuation
- RayzeBio's estimated annual revenue is currently $28.1M per year.
- RayzeBio's estimated revenue per employee is $151,042
- RayzeBio's total funding is $419M.
Employee Data
- RayzeBio has 186 Employees.
- RayzeBio grew their employee count by 51% last year.
RayzeBio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | SVP, Biology & Translational Medicine | Reveal Email/Phone |
4 | SVP, Chemistry Innovation | Reveal Email/Phone |
5 | SVP Clinical Operations | Reveal Email/Phone |
6 | SVP, Chemistry & Head Discovery | Reveal Email/Phone |
7 | SVP, Finance | Reveal Email/Phone |
8 | General Counsel | Reveal Email/Phone |
9 | SVP, Head Commercial and Business Operations | Reveal Email/Phone |
10 | SVP, Chemistry | Reveal Email/Phone |
RayzeBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is RayzeBio?
Leader in targeted radiopharmaceuticals to improving cancer patient survival. Broad pipeline of innovative drugs against solid tumor targets
keywords:N/A
$419M
Total Funding
186
Number of Employees
$28.1M
Revenue (est)
51%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RayzeBio News
San Diego-based RayzeBio, a pharmaceuticals company which says it is developing targeted radiopharmaceutical drugs for cancer, has raised $108M in its Series C funding. The company said it has now raised a total of $258M. The new funding was led by Venrock Healthcare Capital Partners and also in ...
RayzeBio, Inc., which is discovering and developing a broad pipeline of innovative targeted radiopharmaceutical drugs for cancer, today announced a $108 million Series C financing led by Venrock Healthcare Capital Partners alongside new investors Perceptive Advisors, Vivo Capital, Acuta Capital ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $34M | 186 | -1% | N/A |
#2 | $15M | 186 | 11% | N/A |
#3 | $73.7M | 186 | 18% | N/A |
#4 | $40.4M | 187 | 7% | N/A |
#5 | $36.6M | 188 | 19% | N/A |